Join
Live feed
·
INSIDERFilingvia Quantisnow
Relmada Therapeutics Inc. logo

Chief Executive Officer Traversa Sergio bought $178,095 worth of shares (265,976 units at $0.67), increasing direct ownership by 36% to 1,000,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RLMD· Relmada Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RLMD (Relmada Therapeutics Inc.) and more on Quantisnow.

Chief Executive Officer Traversa Sergio bought $178,095 worth of shares (265,976 units at $0.67), increasing direct ownership by 36% to 1,000,000 units (SEC Form 4) | Quantisnow